ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CGEM Cullinan Therapeutics Inc

23.50
0.71 (3.12%)
May 31 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -32.66M-37.11M-29.77M-32.61M-62.76M-37.61M-45.24M-45.49M
Pre Tax Income -32.46M240.14M-27.41M-28.95M-58.14M-32.21M-39.18M-39.69M
Net Income -12.1M174.9M-24.8M-26.78M-57.96M-32.21M-39.18M-23.8M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -32.66M239.44M-29.77M-32.55M-62.65M-37.54M-45.06M-45.6M
EBITDA -32.64M-37.09M-29.76M-32.55M-62.68M-37.52M-44.72M-45.41M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0018.94M00
Operating Income -22.27M-60.34M-67.95M-132.14M-191.09M
Pre Tax Income -21.65M-59.46M-67.49M151.32M-169.22M
Net Income -20.66M-51.8M-65.57M111.21M-153.16M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -1.736-4.354-1.1671.928-2.768
EBIT -22.27M-60.35M-67.96M144.71M-190.85M
EBITDA -22.17M-60.24M-67.85M-132.04M-190.34M